Colby Pharmaceutical Company

Drug molecules targeting oxidative stress, immunity, cancer and inflammation

Colby Pharmaceuticals acquired Othera Pharmaceuticals in September 2012. Colby is a clinical company developing proprietary drug molecules targeting diseases related to oxidative stress, immunity, cancer, and inflammation.

Company Website

Business Category

Healthcare - Biotech, Life Sciences

Investment Status